126 related articles for article (PubMed ID: 36878305)
21. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
22. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
23. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Wang F; Zhao N; Gao G; Deng HB; Wang ZH; Deng LL; Yang Y; Lu C
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2851-2859. PubMed ID: 32743759
[TBL] [Abstract][Full Text] [Related]
24. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix alterations in low-grade lung adenocarcinoma compared with normal lung tissue by imaging mass spectrometry.
Angel PM; Bruner E; Bethard J; Clift CL; Ball L; Drake RR; Feghali-Bostwick C
J Mass Spectrom; 2020 Apr; 55(4):e4450. PubMed ID: 31654589
[TBL] [Abstract][Full Text] [Related]
26. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
[TBL] [Abstract][Full Text] [Related]
27. Tenascin C in metastasis: A view from the invasive front.
Lowy CM; Oskarsson T
Cell Adh Migr; 2015; 9(1-2):112-24. PubMed ID: 25738825
[TBL] [Abstract][Full Text] [Related]
28. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
Weber BZC; Agca S; Domaniku A; Bilgic SN; Arabaci DH; Kir S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1582-1594. PubMed ID: 35373517
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor.
Swindle CS; Tran KT; Johnson TD; Banerjee P; Mayes AM; Griffith L; Wells A
J Cell Biol; 2001 Jul; 154(2):459-68. PubMed ID: 11470832
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of PELP1 in Lung Adenocarcinoma Promoted E
Zhang D; Dai J; Pan Y; Wang X; Qiao J; Sasano H; Zhao B; McNamara KM; Guan X; Liu L; Zhang Y; Chan MSM; Cao S; Liu M; Song S; Wang L
Pathol Oncol Res; 2021; 27():582443. PubMed ID: 34257530
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor-like repeats of tenascin-C-induced constriction of cerebral arteries via activation of epidermal growth factor receptors in rats.
Fujimoto M; Shiba M; Kawakita F; Liu L; Nakasaki A; Shimojo N; Imanaka-Yoshida K; Yoshida T; Suzuki H
Brain Res; 2016 Jul; 1642():436-444. PubMed ID: 27086972
[TBL] [Abstract][Full Text] [Related]
33. Spatial organization of the tenascin-C microenvironment in experimental and human cancer.
Spenlé C; Gasser I; Saupe F; Janssen KP; Arnold C; Klein A; van der Heyden M; Mutterer J; Neuville-Méchine A; Chenard MP; Guenot D; Esposito I; Slotta-Huspenina J; Ambartsumian N; Simon-Assmann P; Orend G
Cell Adh Migr; 2015; 9(1-2):4-13. PubMed ID: 25611571
[TBL] [Abstract][Full Text] [Related]
34. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL.
Rodrigues M; Yates CC; Nuschke A; Griffith L; Wells A
Tissue Eng Part A; 2013 Sep; 19(17-18):1972-83. PubMed ID: 23541003
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
36. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
37. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
38. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma.
Jin X; Zhou H; Song J; Cui H; Luo Y; Jiang H
Comput Math Methods Med; 2021; 2021():9971353. PubMed ID: 34257701
[TBL] [Abstract][Full Text] [Related]
39. RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.
Bao Y; Zhang S; Zhang X; Pan Y; Yan Y; Wang N; Ren Y; Zuo J; Zong WX; Wang Z; Wang Y
Cancer Res; 2023 May; 83(9):1490-1502. PubMed ID: 36853175
[TBL] [Abstract][Full Text] [Related]
40. Loss of G-protein-signaling modulator 2 accelerates proliferation of lung adenocarcinoma via EGFR signaling pathway.
Deng M; Liu B; Zhang Z; Chen Y; Wang Y; Wang X; Lv Q; Yang X; Hou K; Che X; Qu X; Liu Y; Zhang Y; Hu X
Int J Biochem Cell Biol; 2020 May; 122():105716. PubMed ID: 32058048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
